Department of Public Health, Graduate School, Konyang University, Daejeon 35365, Korea.
Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon 35365, Korea.
Int J Environ Res Public Health. 2021 Nov 16;18(22):12035. doi: 10.3390/ijerph182212035.
Vaccination against COVID-19 is an important strategy for its control. Assessing the willingness to accept the COVID-19 vaccine in different subgroups is important for an inclusive vaccination program design. Our aim was to determine the COVID-19 vaccine acceptance rate and associated factors among foreigners in South Korea. An online cross-sectional study was carried out from May to June 2021. In this study, 710 individuals participated and most were aged between 26 and 29 (36.1%) years. Overall, 70.8% were willing to receive the vaccine. Males were less likely to accept the vaccine than females (OR: 0.5; 95% CI: 0.4-0.7, < 0.001). Single people were more likely to receive the vaccine than those who were married (OR: 1.4; 95% CI: 0.9-2.0, = 0.04). Other factors associated with willingness to accept COVID-19 vaccine were; vaccine convenience (OR: 1.7; 95% CI: 1.2-2.3, = 0.002), doctors' recommendation (OR: 2.8; 95% CI: 2.0-3.9, < 0.001), vaccine price (OR: 1.7; 95% CI: 1.2-2.3, = 0.003), vaccine effectiveness (OR: 8.3; 95% CI: 5.8-12.1, < 0.001), vaccine importance (OR: 7.9; 95% CI: 4.6-14.1, < 0.001), and vaccine safety (OR: 6.9; 95% CI: 4.5-10.8, < 0.001). Providing more information on vaccine safety and effectiveness is required to increase vaccine acceptance.
接种 COVID-19 疫苗是控制该疾病的一项重要策略。评估不同亚组人群对接种 COVID-19 疫苗的意愿，对于制定包容性疫苗接种计划至关重要。本研究旨在确定韩国外国人对 COVID-19 疫苗的接种率及相关因素。这是一项 2021 年 5 月至 6 月进行的在线横断面研究。该研究共纳入 710 名参与者，年龄主要集中在 26 至 29 岁（36.1%）。总体而言，70.8%的参与者愿意接种疫苗。与女性相比，男性接种疫苗的意愿较低（OR：0.5；95%CI：0.4-0.7， < 0.001）。单身人群比已婚人群更愿意接种疫苗（OR：1.4；95%CI：0.9-2.0， = 0.04）。与愿意接种 COVID-19 疫苗相关的其他因素包括：疫苗便利性（OR：1.7；95%CI：1.2-2.3， = 0.002）、医生推荐（OR：2.8；95%CI：2.0-3.9， < 0.001）、疫苗价格（OR：1.7；95%CI：1.2-2.3， = 0.003）、疫苗有效性（OR：8.3；95%CI：5.8-12.1， < 0.001）、疫苗重要性（OR：7.9；95%CI：4.6-14.1， < 0.001）和疫苗安全性（OR：6.9；95%CI：4.5-10.8， < 0.001）。为了提高疫苗接种率，需要提供更多关于疫苗安全性和有效性的信息。
